Study Protocol of European Regulatory Science on Tobacco (EUREST-PLUS): Policy implementation to reduce lung disease
More details
Hide details
European Network on Smoking and Tobacco Prevention (ENSP), Brussels, Belgium
University of Crete (UoC), Heraklion, Greece
Kantar Public (TNS), Brussels, Belgium
Smoking or Health Hungarian Foundation (SHHF), Budapest, Hungary
Institut Català d’Oncologia (ICO) and Bellvitge Biomedical Research Institute (IDIBELL), Catalonia, Spain
School of Medicine and Health Sciences, Universitat de Barcelona, Catalonia, Spain
King’s College London (KCL), London, United Kingdom
Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Heidelberg, Germany
University of Athens (UoA), Athens, Greece
University of Medicine and Pharmacy ‘Grigore T. Popa’, Iasi, Romania
Aer Pur Romania, Bucharest, Romania
European Respiratory Society (ERS), Lausanne, Switzerland
School CAPHRI, University of Maastricht (UniMaas), Maastricht, The Netherlands
Health Promotion Foundation (HPF), Warsaw, Poland
University of Waterloo (UW), Waterloo, Canada
Ontario Institute for Cancer Research, Toronto, Canada
Publish date: 2018-08-21
Tob. Induc. Dis. 2018;16(Suppl 2):A2
*EUREST PLUS Consortium List as collaborators: European Network on Smoking and Tobacco Prevention (ENSP), Belgium: Constantine Vardavas, Andrea Glahn, Christina N. Kyriakos, Dominick Nguyen, Cornel Radu-Loghin, Polina Starchenko University of Crete (UoC), Greece: Aristidis Tsatsakis, Charis Girvalaki, Sophia Papadakis, Manolis Tzatzarakis, Alexander Vardavas Kantar Public (TNS), Belgium: Nicolas Bécuwe, Lavinia Deaconu, Sophie Goudet, Christopher Hanley, Oscar Rivière Smoking or Health Hungarian Foundation (SHHF), Hungary: Tibor Demjén, Judit Kiss, Anna Piroska Kovacs Catalan Institut of Oncology (ICO); Bellvitge Biomedical Research Institute (IDIBELL), Spain: Esteve Fernández, Yolanda Castellano, Marcela Fu, Olena Tigova, Sarah Nogueira Kings College London (KCL), United Kingdom: Ann McNeill, Katherine East, Sara C. Hitchman Cancer Prevention Unit and WHO Collaborating Centre for Tobacco Control, German Cancer Research Center (DKFZ), Germany: Ute Mons, Sarah Kahnert University of Athens (UoA), Greece: Yannis Tountas, Panagiotis Behrakis, Filippos T. Filippidis, Christina Gratziou, Paraskevi Katsaounou, Theodosia Peleki, Ioanna Petroulia, Chara Tzavara University of Medicine and Pharmacy ‘Grigore T.Popa’ Iasi, Romania: Antigona Trofor, Marius Eremia, Lucia Lotrean, Florin Mihaltan European Respiratory Society (ERS), Switzerland; Goethe University Frankfurt, Germany: Gernot Werde, Tamaki Asano, Claudia Cichon, Amy Far, Céline Genton, Melanie Jessner, Linnea Hedman, Christer Janson, Ann Lindberg, Beth Maguire, Sofia Ravara, Valérie Vaccaro, Brian Ward University of Maastricht (UniMaas), Netherlands: Marc Willemsen, Hein de Vries, Karin Hummel, Gera Nagelhout Health Promotion Foundation (HPF), Poland: Witold A. Zatoński, Aleksandra Herbeć, Kinga Janik- Koncewicz, Krzysztof Przewoźniak, Mateusz Zatoński University of Waterloo (UW); Ontario Institute for Cancer Research, Canada: Geoffrey T. Fong, Thomas Agar, Pete Driezen, Shannon Gravely, Anne C.K. Quah, Mary E. Thompson
Efforts to mitigate the devastation of tobacco-attributable morbidity and mortality in the European Union (EU) are founded on its newly adopted Tobacco Products Directive (TPD) along with the first-ever health treaty, the WHO Framework Convention on Tobacco Control (FCTC). The aim of this Horizon 2020 Project entitled European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Disease (EURESTPLUS) is to monitor and evaluate the impact of the implementation of the TPD across the EU, within the context of WHO FCTC ratification. To address this aim, EUREST-PLUS consists of four objectives: 1) To create a cohort study of 6000 adult smokers in six EU MS (Germany, Greece, Hungary, Poland, Romania, Spain) within a pre-TID vs post- TPD implementation study design; 2) To conduct secondary dataset analyses of the Special Eurobarometer on Tobacco Survey (SETS); 3) To document changes in e-cigarette product parameters (technical design, labelling/packaging and chemical composition) pre-TID vs post-TPD; and 4) To enhance innovative joint research collaborations on chronic non-communicable diseases. Through this methodological approach, EUREST-PLUS is designed to generate strong inferences about the effectiveness of tobacco control policies, as well as to elucidate the mechanisms and factors by which policy implementation translates to population impact. Findings from EUREST-PLUS have potential global implications for the implementation of innovative tobacco control policies and its impact on the prevention of lung diseases.
Constantine I. Vardavas   
European Network on Smoking and Tobacco Prevention (ENSP), Brussels, Belgium
1. World Health Organization. Who Report on the Global Tobacco Epidemic, 2017. World Health Organization; 2017:1-263.
2. World Health Organization. The European Tobacco Control Report 2007. Copenhagen, Denmark: WHO Regional Office for Europe; 2007:16.
3. Peto R, Lopez AD, Boreham J, Thun MJ. Mortality from smoking in developed countries 1950-2000. 2nd ed. Geneva; Switzerland: International Union Against Cancer (UICC); 2006.
4. Tsalapati K, Vardavas CI, Athanasakis K, et al. Going up in ashes? Smoking-attributable morbidity, hospital admissions and expenditure in Greece. Eur J Public Health. 2014;24(3):477-479. doi:10.1093/eurpub/cku040
5. Max W. The Financial Impact of Smoking on Health-Related Costs: A Review of the Literature. Am J Heal Promot. 2001;15(5):321-331. doi:10.4278/0890-1171-15.5.321
6. Directive 2014/40/EU of the European Parliament and of the Council of 3 April 2014 on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products and repealing Directive 2001/37/EC, OJ 2014 L 127/1. 2001. (Tobacco Products Directive)
7. World Health Organization. WHO Framework Convention on tobacco control. Geneva: World Health Organization; 2003.
8. HETOC. Mapping of best practices and development of testing methods and procedures for identification of characterising flavours in tobacco products. Luxembourg: Publications Office of the European Union; 2016.
9. EUREST. Study on the identification of potential risks to public health associated with the use of refillable electronic cigarettes and development of technical specifications for refill mechanisms. Final Report. Potential Risks from Electronic Cigarettes & their technical Specifications in Europe (PRECISE). Luxembourg: Publications Office of the European Union; 2016.
10. EUREST. Study on the assessment of available evidence on toxicity, addictiveness and attractiveness of ingredients contained in tobacco and related products on the basis of information submitted by the industry in the context of reporting obligations introduced by Directive 2001/37/EC. Final Report. Database of Industry Research on the addictive and Carcinogenic additives in Tobacco. (DIRECT). Luxembourg: Publications Office of the European Union; 2016.
11. Fong GT, Cummings KM, Borland R, et al. The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control. 2006;15(suppl_3):iii3-iii11. doi:10.1136/tc.2005.015438
12. Becker MH. The Health Belief Model and Sick Role Behavior. Health Educ Monogr. 1974;2(4):409-419. doi:10.1177/109019817400200407
13. Bandura A. Social foundations of thought and action: A social-cognitive theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
14. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179-211. doi:10.1016/0749-5978(91)90020-t
15. Rogers R, Prentice-Dunn S. Protection Motivation Theory. New York: Plenum; 1997:113-132
16. International Agency for Research on Cancer. Effectiveness of tax and price policies for tobacco control: IARC Handbook of Cancer Prevention. Vol. 14. 2011:14.
17. European Commission. Special Eurobarometer 458. Attitudes of Europeans towards tobacco and electronic cigarettes. Fieldwork March 2017. 2017:32.
18. Feliu A, Filippidis FT, Joossens L, et al. Impact of tobacco control policies on smoking prevalence and quit ratios in 27 European Union countries from 2006 to 2014. Tob Control. 2018. doi:10.1136/tobaccocontrol-2017-054119
19. Filippidis F, Agaku I, Vardavas C. Transition from experimentation with tobacco and nicotine products to regular smoking in Europe. Tob Induc Dis. 2018;16(1). doi:10.18332/tid/84024
20. Rajani NB, Vlachantoni IT, Vardavas CI, Filippidis FT. The association between occupational secondhand smoke exposure and life satisfaction among adults in the European Union. Tob Induc Dis. 2017;15(1):19. doi:10.1186/s12971-017-0127-x
21. Filippidis FT, Girvalaki C, Mechili E-A, Vardavas CI. Are political views related to smoking and support for tobacco control policies? A survey across 28 European countries. Tob Induc Dis. 2017;15:45. doi:10.1186/s12971-017-0151-x
22. Filippidis FT, Laverty AA, Fernandez E, Mons U, Tigova O, Vardavas CI. Correlates of self-reported exposure to advertising of tobacco products and electronic cigarettes across 28 European Union member states. Tob Control. 2017;26(e2):e130-e133. doi:10.1136/tobaccocontrol-2016-053479
23. Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control. 2017;26(1):98-104. doi:10.1136/tobaccocontrol-2015-052771
24. E-cigarette experimentation and support for tobacco control policies in the European Union. Filippidis FT, Vardavas C. 6.3 Tobacco, Smoking Control and Health Education. European Respiratory Society; 2016: PA2018. doi:10.1183/13993003.congress-2016.pa2018
25. Exposure to e-cigarette advertising in the European Union. Filippidis FT, Vardavas C. 6.3 Tobacco, Smoking Control and Health Education. European Respiratory Society; 2016:PA2017. doi:10.1183/13993003.congress-2016.pa2017
26. Filippidis FT, Laverty AA, Vardavas CI. Experimentation with e-cigarettes as a smoking cessation aid: a cross-sectional study in 28 European Union member states. BMJ Open. 2016;6(10):e012084. doi:10.1136/bmjopen-2016-012084
27. Laverty AA, Filippidis FT, Fernandez E, Vardavas CI. E-cigarette use and support for banning e-cigarette use in public places in the European Union. Prev Med. 2017;105:10-14. doi:10.1016/j.ypmed.2017.08.007
28. Laverty AA, Vardavas CI, Filippidis FT. Design and marketing features influencing choice of e-cigarettes and tobacco in the EU: Table 1. Eur J Public Health. 2016;26(5):838-841. doi:10.1093/eurpub/ckw109
29. Vardavas C, Girvalaki C, Vardavas A, et al. Respiratory irritants in e-cigarette refill liquids across nine European countries: a threat to respiratory health? Eur Respir J. 2017;50(6):1701698. doi:10.1183/13993003.01698-2017
30. Institute of Medicine (US) Committee for the Study of the Future of Public Health. The Future of Public Health. Washington, DC: National Academies Press; 1988. doi:10.17226/1091
31. World Health Organization. WHO report on the global tobacco epidemic, 2017: monitoring tobacco use and prevention policies; Executive Summary. Geneva: World Health Organization; 2017.
32. Glahn A, Kyriakos CN, Radu Loghin C, et al. Tobacco control achievements and priority areas in the WHO Europe Region: A review. Tobacco Prevention & Cessation. 2018;4(April). doi:10.18332/tpc/89925
33. Eurostat. Purchasing power parities (PPPs), price level indices and real expenditures. Accessed November 10, 2017.
34. International Monetary Fund. World Economic Outlook Database. October 2017. Accessed April 2, 2018.
35. Joossens L, Raw M. The tobacco control scale 2016 in Europe. Brussels: Association of European Cancer Leagues; 2016:1-30.
36. Joossens L, Raw M. The tobacco control scale 2013 in Europe. Brussels: Association of European Cancer Leagues; 2014.